Critical Reviews in Oncology/Hematology (CRO/H)

Critical Reviews in Oncology/Hematology is an international peer reviewed journal that publishes authoritative and comprehensive review articles covering all major aspects of cancer research and blood related disorders. The journal focuses on critical evaluation of current advances in basic, translational, and clinical oncology and hematology. Articles synthesize recent developments in tumor biology, diagnostic techniques, and therapeutic approaches, providing clinicians and researchers with in depth perspectives on evolving trends in cancer management. The journal emphasizes evidence based analysis and aims to bridge the gap between laboratory research and clinical practice. Topics include molecular mechanisms of cancer progression, targeted therapies, immunotherapy, biomarkers, hematologic malignancies, and supportive care in oncology. By publishing state of the art reviews written by leading experts, the journal serves as a key reference source for oncologists, hematologists, pathologists, and biomedical scientists. Its mission is to promote improved understanding of malignant and hematologic diseases and to support the development of innovative diagnostic and therapeutic strategies that enhance patient outcomes.

Critical Reviews in Oncology/Hematology (CRO/H) is :-

• International, Peer-Reviewed, Open Access, Refereed, Oncology, Basic Experimental Oncology, Career Development and Education in Oncology, Clinical Research, Immunotherapy, Molecular Pathology, Genomics and omics, Liquid Biopsy, Palliative Support, Pediatric Oncology, Radiotherapy, Regulatory, Ethics, Health Policy , Online or Print , Bi-Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1040-8428, E-ISSN: 1879-0461, Established: 1991, Impact Factor: 5.6
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE